H.R.27 — HALT Fentanyl Act
House Roll Call
H.R.27
| Bill | H.R.27 — HALT Fentanyl Act |
|---|---|
| Vote question | On Passage |
| Vote type | Yea-and-Nay |
| Result | Passed |
| Totals | Yea 312 / Nay 108 / Present 0 / Not Voting 13 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 214 | 1 | 0 | 3 |
| D | 98 | 107 | 0 | 10 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Passage
Bill Analysis
The HALT Fentanyl Act (HR 27) aims to address the escalating crisis of fentanyl trafficking and its associated public health impacts in the United States. This legislation seeks to permanently classify fentanyl-related substances as Schedule I drugs under the Controlled Substances Act, thereby enhancing law enforcement’s ability to combat the distribution and misuse of these potent synthetic opioids.
Key provisions of the bill include the establishment of a permanent classification for fentanyl analogs, which are currently subject to temporary scheduling. This change is designed to close loopholes that allow manufacturers to modify chemical structures to evade existing regulations. The bill also mandates the Department of Justice (DOJ) to prioritize the prosecution of individuals involved in the trafficking of these substances, thereby increasing penalties for offenders.
The HALT Fentanyl Act allocates resources to the Drug Enforcement Administration (DEA) and other law enforcement agencies to bolster their capabilities in detecting and intercepting fentanyl shipments. It also supports initiatives aimed at enhancing public awareness and education regarding the dangers of fentanyl, particularly in vulnerable populations.
Beneficiaries of this legislation include law enforcement agencies, public health officials, and communities adversely affected by the opioid crisis. By imposing stricter regulations on fentanyl-related substances, the bill aims to reduce the availability of these drugs, ultimately protecting individuals at risk of addiction and overdose.
The bill was introduced in the House of Representatives and has progressed to the Senate, where it has been read twice and referred to the Committee on the Judiciary for further consideration. The timeline for potential enactment remains contingent on the legislative calendar and committee deliberations, but the urgency of the fentanyl crisis underscores the need for expedited action.
Yea (312)
K
Ken Calvert
S
Scott Franklin
M
Mark Green
J
John Mannion
L
Lisa McClain
J
John Rutherford
D
David Schweikert
P
Pete Sessions
E
Eric Swalwell
D
Debbie Wasserman Schultz
Nay (108)
G
Gerald Connolly
J
Jason Crow
L
Lloyd Doggett
J
John Garamendi
L
Lucy McBath
R
Rashida Tlaib
S
Sylvester Turner
N
Nydia Velázquez
